COVID-19 pneumonia in a dual heart –kidney recipient
A 61-year-old African American man with a history of hypertension, coronary artery disease, end-stage renal disease (on hemodialysis since 2014), and end-stage heart failure secondary to arrhythmogenic right ventricular cardiomyopathy underwent dual organ heart –kidney transplantation in May 2019. Approximately 2 months after transplant, mycophenolate was discontinued owing to episodes of pancreatitis, leukopenia, and detectable BK polyomavirus. Since then, the patient was maintained on tacrolimus (goal level of 8 ng/ml) and low-dose prednisone (5 mg/day ).
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Maxine W. Stachel, Claudia G. Gidea, Alex Reyentovich, Sapna A. Mehta, Nader Moazami Source Type: research
More News: Cardiology | Cardiomyopathy | COVID-19 | Dialysis | Heart | Heart Failure | Heart Transplant | Hemodialysis | Hypertension | Kidney Transplant | Kidney Transplantation | Lung Transplant | Pancreatitis | Pneumonia | Prednisone | Prograf | Tacrolimus | Transplant Surgery | Transplants | Urology & Nephrology